2 citations
,
January 2020 in “Libri Oncologici Croatian Journal of Oncology” PRP injections improve intestinal healing in rabbits with fewer complications than soaking.
16 citations
,
July 2018 in “Dermatologic Surgery” iL-PRF treatment improves hair growth for androgenetic alopecia.
12 citations
,
December 2020 in “Frontiers in Cell and Developmental Biology” The review found that the way Platelet-Rich Plasma is made varies a lot, which can change the results of medical treatments.
3 citations
,
April 2023 in “Urology Herald” PRP shows promise in treating urological diseases but needs more research.
Regulatory measures are needed to ensure safe production and use of platelet concentrates in Brazil.
26 citations
,
January 2025 in “iScience” PRP helps tissue repair but lacks standard preparation methods.
January 2026 in “RSC Advances” The hydrogel speeds up diabetic wound healing and reduces scarring.
February 2026 in “Frontiers in Pharmacology” Platelet-rich plasma can help heal difficult gastrointestinal fistulas after surgery.
December 2024 in “Biological and Clinical Sciences Research Journal” Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.
134 citations
,
October 2020 in “Preprints.org” Platelet-rich plasma shows promise in healing and treating musculoskeletal issues, but translating lab results to human treatments is challenging.
Combining platelet-rich plasma with other treatments may improve hair growth in androgenetic alopecia.
Combining platelet-rich plasma with other treatments may improve hair growth in androgenetic alopecia.
April 2023 in “Australasian Journal of Dermatology” Both methods of platelet-rich plasma showed positive effects on hair loss.
23 citations
,
June 2018 in “Facial Plastic Surgery” Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.
January 2024 in “Journal of Education, Health and Sport” More research is needed to fully understand the benefits of platelet-rich plasma in medicine.
October 2025 in “Infection Control and Hospital Epidemiology” Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.
December 2019 in “Case medical research”
7 citations
,
December 2018 in “Discoveries” Platelet-rich plasma may improve wound healing by stimulating cell growth and blood vessel formation.
1 citations
,
January 2018 in “Journal of V. N. Karazin Kharkiv National University: Series Medicine” Platelet-rich plasma can positively affect common hair loss, but more research is needed for standard use.
December 2022 in “Plastic and Reconstructive Surgery” PRP is an effective and safe treatment for hair loss.
1 citations
,
September 2020 in “Medicina y Laboratorio” PRP treatment lacks strong evidence for routine use due to poor study quality.
July 2023 in “BENTHAM SCIENCE PUBLISHERS eBooks” Platelet-rich plasma helps heal wounds and regenerate tissue in various medical fields.
7 citations
,
August 2020 in “Journal of The American Academy of Dermatology” The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.
November 2025 in “Journal of Microbiology and Biotechnology” Botulinum toxin type A and platelet-rich plasma together boost hair growth by activating specific growth pathways.
2 citations
,
October 2022 in “Skin appendage disorders” Activated and non-activated PRP are equally safe and effective for treating alopecia areata.
March 2020 in “QJM: An International Journal of Medicine” SVF and PRP improve hair loss, but SVF causes more side effects.
May 2025 in “Journal of medical and dental science research.” i-PRF and A-PRF are promising treatments for hair regrowth in androgenetic alopecia.
April 2021 in “Journal of Investigative Dermatology” PRP treatment helps hair growth and reduces hair loss in women, but more research needed.
May 2025 in “The Journal of Rheumatology” Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.
January 2021 in “Lithuanian University of Health Sciences”